High ENDOG expression was associated with a short time to treatment in a cohort of patients with chronic lymphocytic leukemia (CLL), a B-cell lymphoid neoplasm with activation of PI3K/AKT. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.